Akorn, Inc. is recalling 11,318,367 units of various eye drops and ointments, including Tobramycin (tobramycin), AK-POLY-BAC (bacitracin and polymyxin B), and Artificial Tears, because of deviations from good manufacturing practices. These manufacturing deficiencies could affect the quality and sterility of the medications, which are applied directly to the eye. No incidents or injuries have been reported to date. These products were sold nationwide to pharmacies, hospitals, and eye care professionals.
The manufacturing defects may compromise the sterility and potency of the medications, potentially leading to eye infections or ineffective treatment of existing eye conditions. Because these are ophthalmic products used in a sensitive area, any lack of sterility poses a significant health risk.
You have 2 options:
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.